Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension (2013)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1016/j.redox.2013.11.004
- Subjects: ÓXIDO NÍTRICO; ESTRESSE OXIDATIVO; ENDOTÉLIO VASCULAR; HIPERTENSÃO (EFEITOS DE DROGAS)
- Language: Inglês
- Imprenta:
- Source:
- Título: Redox Biology
- ISSN: 2213-2317
- Volume/Número/Paginação/Ano: v. 1, n. 1, p. 578-585, 2013
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GUIMARÃES, Danielle A. et al. Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension. Redox Biology, v. 1, n. 1, p. 578-585, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2013.11.004. Acesso em: 21 fev. 2026. -
APA
Guimarães, D. A., Rizzi, E., Ceron, C. S., Pinheiro, L. C., Gerlach, R. F., & Tanus-Santos, J. E. (2013). Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension. Redox Biology, 1( 1), 578-585. doi:10.1016/j.redox.2013.11.004 -
NLM
Guimarães DA, Rizzi E, Ceron CS, Pinheiro LC, Gerlach RF, Tanus-Santos JE. Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension [Internet]. Redox Biology. 2013 ; 1( 1): 578-585.[citado 2026 fev. 21 ] Available from: https://doi.org/10.1016/j.redox.2013.11.004 -
Vancouver
Guimarães DA, Rizzi E, Ceron CS, Pinheiro LC, Gerlach RF, Tanus-Santos JE. Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension [Internet]. Redox Biology. 2013 ; 1( 1): 578-585.[citado 2026 fev. 21 ] Available from: https://doi.org/10.1016/j.redox.2013.11.004 - Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension
- Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Circulating matrix metalloproteinases and their inhibitors in hypertension
Informações sobre o DOI: 10.1016/j.redox.2013.11.004 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
